Education
About Us
Working with TipRanks
Follow Us
Myomo Inc (MYO)
:MYO
MYO Analyst Ratings
Strong Buy
5 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MYO Stock 12 Month Forecast
Average Price Target
$9.15
▲(237.64%Upside)
| Highest Price Target$11.50 | Average Price Target$9.15 | Lowest Price Target$6.75 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Ascendiant
$11.5
Buy
324.35%
Upside
Reiterated
06/04/25
We are maintaining our 2025 revenue estimates of $50 million, but adjusting it for EPS to $(0.16) from $0.00. Strong momentum: We expect the company’s recent solid revenue growth (+69% (y-o-y) in 2024, +24% in 2023) to continue over the near-term. We estimate +52% revenue growth in 2025 and +10% in 2026. Focused on MyoPro commercialization: Myomo’s main product, the MyoPro custom fabricated myoelectric upper limb orthosis, is like an exoskeleton for the upper body. Myomo estimates that the addressable U.S. market for its products is $10 billion. In April, Myomo announced the launch of the MyoPro 2x, the latest evolution in its flagship MyoPro product line. Key catalysts expected in 2025: Key catalysts expected in 2025 include continued momentum U.S.
Craig-Hallum
$11→$10
Buy
269.00%
Upside
Reiterated
05/08/25
Alliance Global Partners
$6.75
Buy
149.08%
Upside
Reiterated
05/08/25
H.C. Wainwright
$9.5
Buy
250.55%
Upside
Reiterated
05/08/25
Maxim Group
$7→$8
Buy
195.20%
Upside
Reiterated
05/08/25
Citi
$7.5→$9.5
Buy
250.55%
Upside
Reiterated
03/12/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Ascendiant
$11.5
Buy
324.35%
Upside
Reiterated
06/04/25
We are maintaining our 2025 revenue estimates of $50 million, but adjusting it for EPS to $(0.16) from $0.00. Strong momentum: We expect the company’s recent solid revenue growth (+69% (y-o-y) in 2024, +24% in 2023) to continue over the near-term. We estimate +52% revenue growth in 2025 and +10% in 2026. Focused on MyoPro commercialization: Myomo’s main product, the MyoPro custom fabricated myoelectric upper limb orthosis, is like an exoskeleton for the upper body. Myomo estimates that the addressable U.S. market for its products is $10 billion. In April, Myomo announced the launch of the MyoPro 2x, the latest evolution in its flagship MyoPro product line. Key catalysts expected in 2025: Key catalysts expected in 2025 include continued momentum U.S.
Craig-Hallum
$11→$10
Buy
269.00%
Upside
Reiterated
05/08/25
Alliance Global Partners
$6.75
Buy
149.08%
Upside
Reiterated
05/08/25
H.C. Wainwright
$9.5
Buy
250.55%
Upside
Reiterated
05/08/25
Maxim Group
$7→$8
Buy
195.20%
Upside
Reiterated
05/08/25
Citi
$7.5→$9.5
Buy
250.55%
Upside
Reiterated
03/12/25
Best Analysts Covering Myomo
1 Month
xxx
Success Rate
5/11 ratings generated profit
Average Return
+4.53%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 45.45% of your transactions generating a profit, with an average return of +4.53% per trade.
3 Months
xxx
Success Rate
7/10 ratings generated profit
Average Return
+36.16%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 70.00% of your transactions generating a profit, with an average return of +36.16% per trade.
1 Year
Success Rate
5/11 ratings generated profit
Average Return
+132.59%
reiterated a buy rating 17 days ago
Copying Edward Woo's trades and holding each position for 1 Year would result in 45.45% of your transactions generating a profit, with an average return of +132.59% per trade.
2 Years
xxx
Success Rate
5/11 ratings generated profit
Average Return
+156.23%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 45.45% of your transactions generating a profit, with an average return of +156.23% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MYO Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Mar 25
May 25
Jun 25
Strong Buy
6
3
5
7
8
Buy
5
6
8
7
5
Hold
0
0
1
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
11
9
14
15
14
Each month's total comprises the sum of three months' worth of ratings.
MYO Financial Forecast
MYO Stock Forecast FAQ
What is MYO’s average 12-month price target, according to analysts?
Based on analyst ratings, Myomo Inc’s 12-month average price target is 9.15.
What is MYO’s upside potential, based on the analysts’ average price target?
Myomo Inc has 237.64% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MYO a Buy, Sell or Hold?
Myomo Inc has a consensus rating of Strong Buy which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
What is Myomo Inc’s price target?
The average price target for Myomo Inc is 9.15. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $11.50 ,the lowest forecast is $6.75. The average price target represents 237.64% Increase from the current price of $2.71.
The highest analyst price target is $11.50 ,the lowest forecast is $6.75. The average price target represents 237.64% Increase from the current price of $2.71.
What do analysts say about Myomo Inc?
Myomo Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
How can I buy shares of MYO?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.